Decreasing mortality from acute myocardial infarction: Effect of incidence and prognosis

European Journal of Preventive Cardiology

Volumn 6, Issue 2, 1999, Pages 69-75

  Salomaa, Veikko ^a   Rosamond, Wayne ^b   Mã¤hã¶nen, Markku ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b IL   (United States)

Author keywords

coronary disease; incidence; myocardial Infarction

Indexed keywords

ACUTE HEART INFARCTION; AGE DISTRIBUTION; CARDIOVASCULAR RISK; CLINICAL PRACTICE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR;

HUMANS; INCIDENCE; MYOCARDIAL INFARCTION; PROGNOSIS; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; WORLD HEALTH;

EID: 84992781256     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/204748739900600203     Document Type: Article

References (46)

1. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988; 41: 155–178.
2. Feinleib M. Trends in heart disease in the United States. Am J Med Sci 1995; 310 (suppl 1): S8–S14.
3. Havlik RJ, Feinleib M (editors). Proceedings of the conference on the Decline in Coronary Heart Disease Mortality. Bethesda, MD: National Institutes of Health, May 1979. (National Institutes of Health Publication no 79–1610.)
4. Beaglehole R. International trends in coronary heart disease mortality, morbidity, and risk factors. Epidemiol Rev 1990; 12: 1–14.
5. Hunink M, Goldman L, Tosteson A, Mittleman R, Goldman P, Williams R, et al The recent decline in mortality from coronary heart disease, 1980–1990: The effect of secular trends in risk factors and treatment. JAMA 1997; 277: 535–542.
6. Statistically sophisticated analysis of computer-simulation state-transition models, which suggest that approximately a quarter of the decline in CHD mortality during the 1980s can be explained by primary prevention and over 70% explained by secondary reduction in risk factors or improvements in treatment of patients with CHD.
7. Tunstall-Pedoe H, on behalf of the WHO MONICA Project. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 1988; 41: 105–114.
8. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687–702.
9. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389.
10. A landmark study, which convincingly showed the effect of cholesterol lowering in patients with CHD.
11. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutheford JD, Cole TG, et al The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001–1009.
12. This study showed that the benefits of cholesterol lowering in CHD patients extend to persons with average cholesterol levels.
13. Sans S, Kesteloot H, Kromhout D and the Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. The burden of cardiovascular diseases mortality in Europe. Eur Heart J 1997; 18: 1231–1248.
14. A major document on cardiovascular mortality and morbidity statistics in Europe, also including information from eastern Europe and from smaller areas within each country.
15. American Heart Association. 1998 Heart and Stroke Statistical Update. Dallas, Texas: American Heart Association; 1997.
16. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 1994; 309: 23–27.
17. An interesting analysis based on a long series of standardized risk factor surveys and mortality statistics in the same population.
18. Sytkowski PA, Kannel WB, D'Agostino RA. Changes in risk factors and the decline in mortality from cardiovascular disease. N Engl J Med 1990; 322: 1635–1641.
19. This paper from the Framingham Study presents data on changes in the prevalence and incidence of CHD, which are not easily available elsewhere.
20. Sigfusson N, Sigvaldason H, Steingrimsdottir L, Gudmundsdottir II, Stefansdottir I, Thorsteinsson T, Sigurdsson G. Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ 1991; 302: 1371–1375.
21. Wilhelmsen L. Cardiovascular monitoring of a city over 50 years. Eur Heart J 1997; 18: 1220–1230.
22. A valuable report based on long experience in monitoring of the occurrence of cardiovascular diseases and their risk factors in the city of Gothenburg, Sweden.
23. McGovern PG, Pankow JS, Shahar E, Dolizny KM, Folsom AR, Blackburn H, Luepker RV. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. N Engl J Med 1996; 334: 884–890.
24. This paper demonstrates improved short-term and long-term prognosis of myocardial infarction patients in Minnesota and suggests that medical care had a stronger effect than primary prevention in the late 1980s.
25. Bots ML, Grobbee DE. Decline of coronary heart disease mortality in the Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors. J Cardiovasc Risk 1996; 3: 271–276.
26. Frost PH, Davis BR, Burlando AJ, Curb JD, Gurthrie GP, Isaacsohn JL, et al Coronary heart disease risk factors in men and women aged 60 years and older: findings from the Systolic Hypertension in the Elderly Program. Circulation 1996; 94: 26–34.
27. Tervahauta M, Pekkanen J, Nissinen A. Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease. Finish cohorts of the Seven Countries Study. J Am Coll Cardiol 1995; 26: 1623–1629.
28. Despite its small size this prospective study succeeds in showing the effect of risk factors in elderly men with CHD.
29. Salomaa V, Miettinen H, Kuulasmaa K, Niemela M, Ketonen M, Vuorenmaa T, et al Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence and case-fatality. The FINMONICA MI Register Study. Circulation 1996; 94: 3130–3137.
30. This paper shows that that the decreased occurrence of recurrent coronary events has played a prominent role in the decline of CHD mortality suggesting a substantial effect of secondary prevention measures and treatment of chronic, symptomatic CHD.
31. Wilhelmsen L, Rosengren A, Johansson S, Lappas G. Coronary heart disease attack rate, incidence and mortality 1975–1994 in Göteborg, Sweden. Eur Heart J 1997; 18: 572–581.
32. This report is based on a long period of data collection using standardized methods and gives a good perspective over a long time.
33. Osler M, Sørensen TIA, Sørensen S, Rostgaard K, Jensen G, Iversen L, et al Trends in mortality, incidence and case-fatality of ischaemic heart disease in Denmark, 1982–1992. Int J Epidemiol 1996; 25: 1154–1161.
34. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill D, Clegg L, et al Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861–867.
35. This is the most recent paper from a major study in the USA. It presents trend data on CHD mortality, myocardial infarction incidence, recurrence, and case fatality for four USA communities. Trends among USA blacks and whites are provided.
36. DeStefano F, Merritt R, Anda R, Casper M, Eaker E. Trends in nonfatal coronary heart disease in the United States, 1980 through 1989. Arch Intern Med 1993; 153: 2489–2494.
37. Marques-Vidal P, Ferrières J, Metzger M-H, Cambou J-P, Filipiak B, Löwel H, Keil U. Trends in coronary heart disease morbidity and mortality and acute coronary care and case fatality from 1985–1989 in southern Germany and south-western France. Results from the MONICA Projects in Augsburg and Toulouse. Eur Heart J 1997; 18: 816–821.
38. Tavazzi L, Volpi A. Remarks about postinfarction prognosis in light of the experience with the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) Trials. Circulation 1997; 95: 1341–1345.
39. Ferrières J, Cambou J-P, Ruidavets J-P, Pous J. Trends in acute myocardial infarction prognosis and treatment in southwestern France between 1985 and 1990. The MONICA Project-Toulouse. Am J Cardiol 1995; 75: 1202–1205.
40. An interesting article on case fatality trends from an area where the use of modern treatments has been very active.
41. Hopper JL, Pathik B, Hunt D, Chan WWC. Improved prognosis of myocardial infarction treated in a coronary care unit: lack of relation with changes in severity. BMJ 1989; 299: 892–896.
42. Salomaa V, Miettinen H, Palomäki P, Arstila M, Mustaniemi H, Kuulasmaa K, Tuomilehto J, for the FINMONICA AMI Register Study Group. Diagnostic features of acute myocardial infarction - changes over time from 1983 to 1990: results from the FINMONICA AMI register study. J Intern Med 1995; 237: 151–159.
43. Bata IR, Eastwood BJ, Gregor RD, Guernsey Jr., Klassen GA, MacKenzie BR, Wolf HK. Decreasing mortality from acute myocardial infarctions: effect of attack rates and case severity. J Clin Epidemiol 1997; 50: 787–791.
44. Burke GL, Edlavitch SA, Crow RS. The effects of diagnostic criteria on trends in coronary heart disease morbidity: The Minnesota Heart Survey. J Clin Epidemiol 1989; 42: 17–24.
45. Bonneux L, Looman CWN, Barendregt JJ, Van der Maas PJ. Regression analysis of recent changes in cardiovascular morbidity and mortality in the Netherlands. BMJ 1997; 314: 789–792.
46. A fascinating application of vital statistics and hospital discharge register data to give a picture on CHD mortality and morbidity trends in the whole population of The Netherlands.